20 Years Since HPV Vaccine Introduction: Medical Experts Urge Vaccination and Screening to Build Family Protection Networks
AI Summary (NQ-processed)
On the 20th anniversary of the HPV vaccine, medical experts in Taiwan highlight the rising incidence of HPV-related oropharyngeal cancer among men and advocate for early vaccination and screening for both genders. Starting September 2025, male junior high school students will be included in the public vaccination program, making Taiwan the first in East Asia to offer fully publicly funded HPV vaccination for both boys and girls.
AI Analysis
Frequently Asked Questions
Q: Is the HPV vaccine effective for men?
A: Yes. Men are at risk for oropharyngeal cancer and genital warts, and vaccination protects both themselves and their partners.
Q: When will HPV vaccination be available for boys in Taiwan?
A: Starting September 2025, first-year junior high school boys will be eligible for publicly funded HPV vaccination.
Q: Should adults get the HPV vaccine?
A: Yes. Since infection often begins in youth, catch-up vaccination is recommended for unvaccinated adults.
Q: What is the link between HPV and oropharyngeal cancer in Taiwan?
A: 25–30% of oropharyngeal cancers in Taiwan are HPV-related, with types 52, 58, and 33 being prevalent, compounded by smoking and alcohol.
Q: How can families prevent HPV together?
A: Key steps include early adolescent vaccination, adult catch-up doses, and shared awareness and screening between genders.